PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2009. Start Trial.
Date Value
October 07, 2026 0.3828
October 06, 2026 0.3828
October 05, 2026 0.3828
October 02, 2026 0.3828
October 01, 2026 0.3828
September 30, 2026 0.3828
September 29, 2026 0.3828
September 28, 2026 0.3828
September 25, 2026 0.3828
September 24, 2026 0.3828
September 23, 2026 0.3828
September 22, 2026 0.3828
September 21, 2026 0.3828
September 18, 2026 0.4243
September 17, 2026 0.4243
September 16, 2026 0.4243
September 15, 2026 0.4243
September 14, 2026 0.4243
September 11, 2026 0.4243
September 10, 2026 0.4243
September 09, 2026 0.4243
September 08, 2026 0.4243
September 04, 2026 0.4243
September 03, 2026 0.4243
September 02, 2026 0.4243
Date Value
September 01, 2026 0.4243
August 31, 2026 0.4243
August 28, 2026 0.4243
August 27, 2026 0.4243
August 26, 2026 0.4243
August 25, 2026 0.4243
August 24, 2026 0.4243
August 21, 2026 0.4104
August 20, 2026 0.4104
August 19, 2026 0.4104
August 18, 2026 0.4104
August 17, 2026 0.4104
August 14, 2026 0.4104
August 13, 2026 0.4104
August 12, 2026 0.4104
August 11, 2026 0.4104
August 10, 2026 0.3841
August 07, 2026 0.3841
August 06, 2026 0.4175
August 05, 2026 0.4175
August 04, 2026 0.4175
August 03, 2026 0.4175
July 31, 2026 0.4175
July 30, 2026 0.406
July 29, 2026 0.406

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Evotec SE 0.6629
Lifecore Biomedical, Inc. --
Repligen Corp. 11.82
Bio-Techne Corp. 9.358
Codexis, Inc. 1.600

PS Ratio Related Metrics